Medicare Enrolled

Dr. Joel Eichler, MD

Ophthalmology · Belleville, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5 FRANKLIN AVE, Belleville, NJ 07109
9737516060
In practice since 2005 (20 years)
NPI: 1326033598 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eichler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eichler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eichler

Dr. Joel Eichler is an ophthalmology specialist in Belleville, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Eichler performed 19,587 Medicare services across 3,146 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eichler received a total of $2,821 from 22 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eichler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in NJ $2,821 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,587
Medicare services
Top 5% in NJ for ophthalmology
3,146
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~979 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
11,280 $29 $50
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,929 $35 $125
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,316 $108 $758
Aflibercept eye injection (Eylea) 1,114 $682 $2,031
Injection, ranibizumab, 0.1 mg 1,060 $175 $736
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
713 $96 $155
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
386 $53 $263
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
385 $158 $344
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
241 $96 $153
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
199 $72 $110
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
190 $68 $112
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
177 $1,499 $2,831
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
131 $29 $150
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
106 $49 $298
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
85 $41 $65
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
71 $104 $180
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
59 $186 $475
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
56 $20 $85
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $101 $176
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
29 $256 $1,750
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
18 $8 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,821
Total received (2018-2024)
Avg $403/year across 7 years
Top 29% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,821 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$606
2023
$846
2022
$387
2021
$241
2020
$167
2019
$477
2018
$97

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$151
Astellas Pharma US Inc
$148
Genentech USA, Inc.
$70
Amgen Inc.
$68
ABBVIE INC.
$64
Alimera Sciences, Inc.
$50
Bausch & Lomb Americas Inc.
$21
Apellis Pharmaceuticals, Inc.
$18
Harrow Eye, LLC
$17
Top 3 companies account for 60.8% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$711
ABBVIE INC.
$382
Novartis Pharmaceuticals Corporation
$369
Genentech USA, Inc.
$290
Astellas Pharma US Inc
$272
Bausch & Lomb Americas Inc.
$156
Alimera Sciences, Inc.
$68
Amgen Inc.
$68
Sun Pharmaceutical Industries Inc.
$58
Bausch & Lomb, a division of Bausch Health US, LLC
$55
Allergan Inc.
$54
Horizon Therapeutics plc
$48
Oyster Point Pharma, Inc.
$46
Allergan, Inc.
$41
Aerie Pharmaceuticals, Inc.
$41
Kala Pharmaceuticals, Inc.
$38
Eyevance Pharmaceuticals LLC
$37
Biogen, Inc.
$26
Apellis Pharmaceuticals, Inc.
$18
Harrow Eye, LLC
$17
EYEVANCE PHARMACEUTICALS LLC
$15
Alcon Vision LLC
$12
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
BEOVU · BROMSITE · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · DURYSTA · EYLEA · EYLEA HD · Flarex · IHEEZO · ILUVIEN · INFUSE · INVELTYS · Izervay · LOTEMAX SM · LUMIGAN · Lucentis · OZURDEX · PROLENSA · RESTASIS · Rhopressa · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · TobraDex ST · Tobradex ST · VABYSMO · VYZULTA · Vabysmo · XELPROS · XIPERE · YUTIQ · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Belleville?
Compare ophthalmologists in the Belleville area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,294
Per 100K population
151.5
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Eichler is a mixed practice specialist, with above-average Medicare volume (top 5% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Eichler experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Eichler performed 11,280 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eichler receive payments from pharmaceutical companies?
Yes. Dr. Eichler received a total of $2,821 from 22 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eichler's costs compare to other ophthalmologists in Belleville?
Dr. Eichler's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eichler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →